Summary of Significant Accounting Policies (Tables)

6 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.

	Cash, Cash Equivalents and Restricted Cash
	March 31, 2020		March 31, 2019		September 30, 2019		September 30, 2018
Cash and cash equivalents	$	297.3	$	492.1	$	447.1	$	452.6
Restricted cash	104.4		26.3		63.7		9.6
Cash, cash equivalents and restricted cash	$	401.7	$	518.4	$	510.8	$	462.2

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.

	Cash, Cash Equivalents and Restricted Cash
	March 31, 2020		March 31, 2019		September 30, 2019		September 30, 2018
Cash and cash equivalents	$	297.3	$	492.1	$	447.1	$	452.6
Restricted cash	104.4		26.3		63.7		9.6
Cash, cash equivalents and restricted cash	$	401.7	$	518.4	$	510.8	$	462.2

Shares Used in Computing Basic and Diluted Earnings Per Share

Shares used in computing basic and diluted earnings per share are as follows: 

	Three Months Ended March 31,		Six Months Ended March 31,
	2020	2019	2020	2019
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic (a)	208,941	174,501	209,151	174,461
Incremental shares issuable for stock options and awards (b)	867	2,817	1,343	2,985
Weighted-average common shares outstanding — diluted	209,808	177,318	210,494	177,446

(a) The three and six months ended March 31, 2020, reflects the August 2019 issuance of 34,613 shares of UGI Common Stock in connection with the AmeriGas Merger.

(b) For the three and six months ended March 31, 2020 and 2019, there were 8,020 and 208 shares, respectively, associated with outstanding stock option awards that were excluded from the computation of diluted earnings per share above because their effect was antidilutive.